(Q50940137)

25 March 2018

title

HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses. (English)

1 reference

25 March 2018

author

Christopher B. Buck

9

1 reference

25 March 2018

Jorma Hinkula

10

1 reference

25 March 2018

Joakim Dillner

7

object named as

Joakim Dillner

1 reference

25 March 2018

11

Britta Wahren

1 reference

25 March 2018

author name string

Erik Rollman

1

1 reference

25 March 2018

Lisen Arnheim

2

1 reference

25 March 2018

Brian Collier

3

1 reference

25 March 2018

Daniel Oberg

4

1 reference

25 March 2018

Håkan Hall

5

1 reference

25 March 2018

Jonas Klingström

6

1 reference

25 March 2018

Diana V Pastrana

8

1 reference

25 March 2018

Stefan Schwartz

12

1 reference

25 March 2018

language of work or name

English

0 references

publication date

1 April 2004

1 reference

25 March 2018

published in

Virology

1 reference

25 March 2018

volume

322

1 reference

25 March 2018

issue

1

1 reference

25 March 2018

page(s)

182-189

1 reference

25 March 2018

Induction of HIV-1 specific mucosal immune responses by DNA vaccination

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

DNA-plasmids of HIV-1 induce systemic and mucosal immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Biological features of genetic immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Efficient intracellular assembly of papillomaviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Immunological events in regressing genital warts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

L1-specific protection from tumor challenge elicited by HPV16 virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Mapping of linear epitopes of human papillomavirus type 16: The E1, E2, E4, E5, E6 and E7 open reading frames

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Protection against papillomavirus with a polynucleotide vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Human papillomavirus update with a particular focus on cervical disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Immunization of rabbits with cottontail rabbit papillomavirus E1 and E2 genes: protective immunity induced by gene gun-mediated intracutaneous delivery but not by intramuscular injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Natural history of cervicovaginal papillomavirus infection in young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

A controlled trial of a human papillomavirus type 16 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Granulocyte-macrophage colony-stimulating factor priming plus papillomavirus E6 DNA vaccination: effects on papilloma formation and regression in the cottontail rabbit papillomavirus--rabbit model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Chapter 16: Prophylactic human papillomavirus vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Estimating the world cancer burden: Globocan 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Mucosal IgG and IgA responses to human papillomavirus type 16 capsid proteins in HPV16-infected women without visible pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Papillomavirus-like particle based vaccines: cervical cancer and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Human papillomavirus type 16 DNA sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

IMMUNIZATION OF RABBITS TO INFECTIOUS PAPILLOMATOSIS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Detection of CD4(+)- and CD8(+)-T-cell responses to human papillomavirus type 1 antigens expressed at various stages of the virus life cycle by using an enzyme-linked immunospot assay of gamma interferon release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Effect of vaccine delivery system on the induction of HPV16L1-specific humoral and cell-mediated immune responses in immunized rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2004.02.002

1 reference

25 March 2018

1 reference

25 March 2018